Athersys, 3DP Enter Pact to Develop, Commercialize Therapeutics | GenomeWeb

NEW YORK, Oct. 29 — Athersys and 3-Dimensional Pharmaceuticals on Monday announced a collaboration to discover and commercialize novel small-molecule pharmaceuticals for disease treatment. 

Terms of the deal call for Cleveland-based Athersys to use its functional genomics technology to complement 3-Dimensional Pharmaceuticals’ drug-development and optimization experience. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.